Linking post-translational modifications and protein turnover by site-resolved protein turnover profiling.


Journal

Nature communications
ISSN: 2041-1723
Titre abrégé: Nat Commun
Pays: England
ID NLM: 101528555

Informations de publication

Date de publication:
10 01 2022
Historique:
received: 01 08 2021
accepted: 02 12 2021
entrez: 11 1 2022
pubmed: 12 1 2022
medline: 11 2 2022
Statut: epublish

Résumé

Proteome-wide measurements of protein turnover have largely ignored the impact of post-translational modifications (PTMs). To address this gap, we employ stable isotope labeling and mass spectrometry to measure the turnover of >120,000 peptidoforms including >33,000 phosphorylated, acetylated, and ubiquitinated peptides for >9,000 native proteins. This site-resolved protein turnover (SPOT) profiling discloses global and site-specific differences in turnover associated with the presence or absence of PTMs. While causal relationships may not always be immediately apparent, we speculate that PTMs with diverging turnover may distinguish states of differential protein stability, structure, localization, enzymatic activity, or protein-protein interactions. We show examples of how the turnover data may give insights into unknown functions of PTMs and provide a freely accessible online tool that allows interrogation and visualisation of all turnover data. The SPOT methodology is applicable to many cell types and modifications, offering the potential to prioritize PTMs for future functional investigations.

Identifiants

pubmed: 35013197
doi: 10.1038/s41467-021-27639-0
pii: 10.1038/s41467-021-27639-0
pmc: PMC8748498
doi:

Substances chimiques

Proteins 0
Proteome 0

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

165

Informations de copyright

© 2022. The Author(s).

Références

Schoenheimer, R. & Clarke, H. T. The Dynamic State of Body Constituents. (Harvard University Press, Cambridge, Massachusetts, USA, 1942).
Hinkson, I. V. & Elias, J. E. The dynamic state of protein turnover: It’s about time. Trends Cell Biol. 21, 293–303 (2011).
pubmed: 21474317 doi: 10.1016/j.tcb.2011.02.002
Balch, W. E., Morimoto, R. I., Dillin, A. & Kelly, J. W. Adapting Proteostasis for Disease Intervention. Science 319, 916–919 (2008).
pubmed: 18276881 doi: 10.1126/science.1141448
Buchberger, A., Bukau, B. & Sommer, T. Protein Quality Control in the Cytosol and the Endoplasmic Reticulum: Brothers in Arms. Mol. Cell 40, 238–252 (2010).
pubmed: 20965419 doi: 10.1016/j.molcel.2010.10.001
Harper, J. W. & Bennett, E. J. Proteome complexity and the forces that drive proteome imbalance. Nature 537, 328–338 (2016).
pubmed: 27629639 pmcid: 5204264 doi: 10.1038/nature19947
Selbach, M. et al. Widespread changes in protein synthesis induced by microRNAs. Nature 455, 58–63 (2008).
pubmed: 18668040 doi: 10.1038/nature07228
Zecha, J. et al. Peptide Level Turnover Measurements Enable the Study of Proteoform Dynamics. Mol. Cell. Proteom. 17, 974–992 (2018).
doi: 10.1074/mcp.RA118.000583
Mathieson, T. et al. Systematic analysis of protein turnover in primary cells. Nat. Commun. 9, 689 (2018).
pubmed: 29449567 pmcid: 5814408 doi: 10.1038/s41467-018-03106-1
Fornasiero, E. F. et al. Precisely measured protein lifetimes in the mouse brain reveal differences across tissues and subcellular fractions. Nat. Commun. 9, 4230 (2018).
pubmed: 30315172 pmcid: 6185916 doi: 10.1038/s41467-018-06519-0
Komander, D. & Rape, M. The Ubiquitin Code. Annu. Rev. Biochem. 81, 203–229 (2012).
pubmed: 22524316 doi: 10.1146/annurev-biochem-060310-170328
Carrano, A. C., Eytan, E., Hershko, A. & Pagano, M. SKP2 is required for ubiquitin-mediated degradation of the CDK inhibitor p27. Nat. Cell Biol. 1, 193–199 (1999).
pubmed: 10559916 doi: 10.1038/12013
Holt, L. J. Regulatory modules: Coupling protein stability to phopshoregulation during cell division. FEBS Lett. 586, 2773–2777 (2012).
pubmed: 22664379 doi: 10.1016/j.febslet.2012.05.045
Li, M., Luo, J., Brooks, C. L. & Gu, W. Acetylation of p53 Inhibits Its Ubiquitination by Mdm2. J. Biol. Chem. 277, 50607–50611 (2002).
pubmed: 12421820 doi: 10.1074/jbc.C200578200
Ito, A. et al. MDM2-HDAC1-mediated deacetylation of p53 is required for its degradation. EMBO J. 21, 6236–6245 (2002).
pubmed: 12426395 pmcid: 137207 doi: 10.1093/emboj/cdf616
Patel, J. H. et al. The c-MYC Oncoprotein Is a Substrate of the Acetyltransferases hGCN5/PCAF and TIP60. Mol. Cell. Biol. 24, 10826–10834 (2004).
pubmed: 15572685 pmcid: 533976 doi: 10.1128/MCB.24.24.10826-10834.2004
Jeong, J.-W. et al. Regulation and Destabilization of HIF-1α by ARD1-Mediated Acetylation. Cell 111, 709–720 (2002).
pubmed: 12464182 doi: 10.1016/S0092-8674(02)01085-1
Hernandez-Hernandez, A. et al. Acetylation and MAPK phosphorylation cooperate to regulate the degradation of active GATA-1. EMBO J. 25, 3264–3274 (2006).
pubmed: 16858405 pmcid: 1523174 doi: 10.1038/sj.emboj.7601228
Kim, W. et al. Systematic and Quantitative Assessment of the Ubiquitin-Modified Proteome. Mol. Cell 44, 325–340 (2011).
pubmed: 21906983 pmcid: 3200427 doi: 10.1016/j.molcel.2011.08.025
Humbert, N. et al. Regulation of ploidy and senescence by the AMPK-related kinase NUAK1. EMBO J. 29, 376–386 (2010).
pubmed: 19927127 doi: 10.1038/emboj.2009.342
Hsu, P. P. et al. The mTOR-Regulated Phosphoproteome Reveals a Mechanism of mTORC1-Mediated Inhibition of Growth Factor Signaling. Science 332, 1317–1322 (2011).
pubmed: 21659604 pmcid: 3177140 doi: 10.1126/science.1199498
Kobayashi, T. et al. Regulation of cytosolic prostaglandin E synthase by phosphorylation. Biochem J. 381, 59–69 (2004).
pubmed: 15040786 pmcid: 1133762 doi: 10.1042/BJ20040118
Kim, T.-S., Kim, H. D. & Kim, J. PKCδ-dependent functional switch of rpS3 between translation and DNA repair. Biochimica et. Biophysica Acta (BBA) - Mol. Cell Res. 1793, 395–405 (2009).
doi: 10.1016/j.bbamcr.2008.10.017
Ventura, M. et al. Nuclear translocation of glyceraldehyde-3-phosphate dehydrogenase is regulated by acetylation. Int J. Biochem Cell Biol. 42, 1672–1680 (2010).
pubmed: 20601085 doi: 10.1016/j.biocel.2010.06.014
Fan, J. et al. Tyr Phosphorylation of PDP1 Toggles Recruitment between ACAT1 and SIRT3 to Regulate the Pyruvate Dehydrogenase Complex. Mol. Cell 53, 534–548 (2014).
pubmed: 24486017 pmcid: 3943932 doi: 10.1016/j.molcel.2013.12.026
Boisvert, F.-M. et al. A Quantitative Spatial Proteomics Analysis of Proteome Turnover in Human Cells. Mol. Cell. Proteom. 11, M111.011429 (2012).
doi: 10.1074/mcp.M111.011429
McShane, E. et al. Kinetic Analysis of Protein Stability Reveals Age-Dependent Degradation. Cell 167, 803–815.e821 (2016).
pubmed: 27720452 doi: 10.1016/j.cell.2016.09.015
Schrader, E. K., Harstad, K. G. & Matouschek, A. Targeting proteins for degradation. Nat. Chem. Biol. 5, 815-822 (2009).
Schwartz, D. & Gygi, S. P. An iterative statistical approach to the identification of protein phosphorylation motifs from large-scale data sets. Nat. Biotechnol. 23, 1391–1398 (2005).
pubmed: 16273072 doi: 10.1038/nbt1146
O’Shea, J. P. et al. pLogo: a probabilistic approach to visualizing sequence motifs. Nat. Methods 10, 1211–1212 (2013).
pubmed: 24097270 doi: 10.1038/nmeth.2646
Okazaki, K. & Sagata, N. The Mos/MAP kinase pathway stabilizes c-Fos by phosphorylation and augments its transforming activity in NIH 3T3 cells. EMBO J. 14, 5048–5059 (1995).
pubmed: 7588633 pmcid: 394608 doi: 10.1002/j.1460-2075.1995.tb00187.x
Weinert, B. T. et al. Time-Resolved Analysis Reveals Rapid Dynamics and Broad Scope of the CBP/p300 Acetylome. Cell 174, 231–244.e212 (2018).
pubmed: 29804834 pmcid: 6078418 doi: 10.1016/j.cell.2018.04.033
Schölz, C. et al. Acetylation site specificities of lysine deacetylase inhibitors in human cells. Nat. Biotechnol. 33, 415–423 (2015).
pubmed: 25751058 doi: 10.1038/nbt.3130
Kang, H. J., Jung, S. K., Kim, S. J. & Chung, S. J. Structure of human alpha-enolase (hENO1), a multifunctional glycolytic enzyme. Acta Crystallogr D. Biol. Crystallogr 64, 651–657 (2008).
pubmed: 18560153 doi: 10.1107/S0907444908008561
Poyner, R. R., Laughlin, L. T., Sowa, G. A. & Reed, G. H. Toward Identification of Acid/Base Catalysts in the Active Site of Enolase: Comparison of the Properties of K345A, E168Q, and E211Q Variants. Biochemistry 35, 1692–1699 (1996).
pubmed: 8634301 doi: 10.1021/bi952186y
Zakaryan, R. P. & Gehring, H. Identification and Characterization of the Nuclear Localization/Retention Signal in the EWS Proto-oncoprotein. J. Mol. Biol. 363, 27–38 (2006).
pubmed: 16965792 doi: 10.1016/j.jmb.2006.08.018
Hagen, L. et al. Cell cycle-specific UNG2 phosphorylations regulate protein turnover, activity and association with RPA. EMBO J. 27, 51–61 (2008).
pubmed: 18079698 doi: 10.1038/sj.emboj.7601958
Mitschke, L. et al. The crystal structure of human transketolase and new insights into its mode of action. J. Biol. Chem. 285, 31559–31570 (2010).
pubmed: 20667822 pmcid: 2951230 doi: 10.1074/jbc.M110.149955
Ahmad, Y., Boisvert, F.-M., Lundberg, E., Uhlen, M. & Lamond, A. I. Systematic Analysis of Protein Pools, Isoforms, and Modifications Affecting Turnover and Subcellular Localization. Mol. Cell. Proteom. 11, M111.013680 (2012).
doi: 10.1074/mcp.M111.013680
Swaney, D. L. et al. Global analysis of phosphorylation and ubiquitylation cross-talk in protein degradation. Nat. methods 10, 676–682 (2013).
pubmed: 23749301 doi: 10.1038/nmeth.2519
Martin-Perez, M. & Villén, J. Determinants and Regulation of Protein Turnover in Yeast. Cell Syst. 5, 283–294.e285 (2017).
pubmed: 28918244 pmcid: 5935796 doi: 10.1016/j.cels.2017.08.008
Wu, C. et al. Global and Site-Specific Effect of Phosphorylation on Protein Turnover. Dev. Cell 56, 25 (2020).
Wu, C. et al. Global and Site-Specific Effect of Phosphorylation on Protein Turnover. Dev. Cell 56, 111–124 e116 (2021).
pubmed: 33238149 doi: 10.1016/j.devcel.2020.10.025
Zecha, J. et al. TMT Labeling for the Masses: A Robust and Cost-efficient, In-solution Labeling Approach. Mol. Cell. Proteom. 18, 1468–1478 (2019).
doi: 10.1074/mcp.TIR119.001385
Ruprecht, B., Zecha, J., Zolg, D. P. & Kuster, B. in Proteomics: Methods and Protocols. (eds. L. Comai, J. E. Katz & P. Mallick) 83–98 (Springer New York, New York, NY; 2017).
Baumann, U. et al. Disruption of the PRKCD–FBXO25–HAX-1 axis attenuates the apoptotic response and drives lymphomagenesis. Nat. Med. 20, 1401–1409 (2014).
pubmed: 25419709 doi: 10.1038/nm.3740
Bian, Y. et al. Robust, reproducible and quantitative analysis of thousands of proteomes by micro-flow LC–MS/MS. Nat. Commun. 11, 157 (2020).
pubmed: 31919466 pmcid: 6952431 doi: 10.1038/s41467-019-13973-x
Gessulat, S. et al. Prosit: proteome-wide prediction of peptide tandem mass spectra by deep learning. Nat. Methods 16, 509–518 (2019).
pubmed: 31133760 doi: 10.1038/s41592-019-0426-7
Kumar, M. et al. ELM-the eukaryotic linear motif resource in 2020. Nucl. Acids Res. 48, D296–D306 (2020).
pubmed: 31680160

Auteurs

Jana Zecha (J)

Chair of Proteomics and Bioanalytics, Technical University of Munich (TUM), Freising, Germany.
German Cancer Consortium (DKTK) and German Cancer Research Center (DKFZ), Heidelberg, Germany.
Dynamic Omics, Centre for Genomics Research, Discovery Sciences, R&D AstraZeneca, Gaithersburg, MD, USA.

Wassim Gabriel (W)

Chair of Proteomics and Bioanalytics, Technical University of Munich (TUM), Freising, Germany.
Computational Mass Spectrometry, Technical University of Munich (TUM), Freising, Germany.

Ria Spallek (R)

Department of Medicine III, Klinikum rechts der Isar, TUM, Munich, Germany.
TranslaTUM, Center for Translational Cancer Research, TUM, Munich, Germany.

Yun-Chien Chang (YC)

Chair of Proteomics and Bioanalytics, Technical University of Munich (TUM), Freising, Germany.

Julia Mergner (J)

Chair of Proteomics and Bioanalytics, Technical University of Munich (TUM), Freising, Germany.
Bavarian Biomolecular Mass Spectrometry Center at Klinikum rechts der Isar (BayBioMS@MRI), TUM, Munich, Germany.

Mathias Wilhelm (M)

Chair of Proteomics and Bioanalytics, Technical University of Munich (TUM), Freising, Germany.
Computational Mass Spectrometry, Technical University of Munich (TUM), Freising, Germany.

Florian Bassermann (F)

German Cancer Consortium (DKTK) and German Cancer Research Center (DKFZ), Heidelberg, Germany.
Department of Medicine III, Klinikum rechts der Isar, TUM, Munich, Germany.
TranslaTUM, Center for Translational Cancer Research, TUM, Munich, Germany.

Bernhard Kuster (B)

Chair of Proteomics and Bioanalytics, Technical University of Munich (TUM), Freising, Germany. kuster@tum.de.
German Cancer Consortium (DKTK) and German Cancer Research Center (DKFZ), Heidelberg, Germany. kuster@tum.de.
Bavarian Biomolecular Mass Spectrometry Center (BayBioMS), TUM, Freising, Germany. kuster@tum.de.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH